Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
KYMR compared with MDGL: revenue, margins and what each company keeps, and the suppliers and customers both name
KYMR
Kymera Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
MDGL
Madrigal Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
KYMR
Kymera Therapeutics, Inc.
vs
MDGL
Madrigal Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
KYMR, solid
MDGL, dashed
KYMR
Kymera Therapeutics, Inc.
Change
130.29
▲
+1.69%
Mkt cap
$10.9B
Revenue
$65M
Q2 FY26
Revenue
$39M
FY25
MDGL
Madrigal Pharmaceuticals, Inc.
Change
389.34
▼
−2.69%
Regular session
Nov 6 '26
Mkt cap
$9.3B
Revenue
$431M
Q3 FY26
Revenue
$958M
FY25
vs
Compare
Regular session
Nov 6 '26
KYMR
Kymera Therapeutics, Inc.
vs
MDGL
Madrigal Pharmaceuticals, Inc.
130.29
▲
+1.69%
Price
389.34
▼
−2.69%
$10.9B
Mkt cap
$9.3B
Q2 FY26
$65M
Revenue
$431M
Q3 FY26
FY25
$39M
Revenue
$958M
FY25
Change
Change
KYMR
130.29
▲
+1.69%
vs
MDGL
389.34
▼
−2.69%
Regular session
Nov 6 '26